Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.61 |
| ▸ | IL1RN | P18510 | 8/20 | 0.59 |
| ▸ | ERAP2 | Q6P179 | 8/20 | 0.59 |
| ▸ | MMP2 | P08253 | 2/20 | 0.57 |
| ▸ | MMP9 | P14780 | 1/20 | 0.57 |
| ▸ | MMP8 | P22894 | 1/20 | 0.57 |
| ▸ | MMP1 | P03956 | 1/20 | 0.57 |
| ▸ | ACE | P12821 | 1/20 | 0.57 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.56 |
| ▸ | ANPEP | P15144 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.56 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17534495 | 1.00 | MEN1 (0.61) | MEN1KMT2AHCRTR1IL1RNERAP2 | |
| SCHEMBL28043198 | 0.92 | KMT2A (0.61) | MEN1KMT2AHCRTR1IL1RNERAP2 | |
| SCHEMBL20829913 | 0.91 | KMT2A (0.66) | MEN1KMT2AHCRTR1IL1RNERAP2 | |
| SCHEMBL30800609 | 0.91 | KMT2A (0.66) | MEN1KMT2AHCRTR1IL1RNERAP2 | |
| SCHEMBL29845269 | 0.89 | IL1RN (0.67) | MEN1KMT2AHCRTR1IL1RNERAP2 | |
| SCHEMBL7398615 | 0.89 | IL1RN (0.67) | MEN1KMT2AHCRTR1IL1RNERAP2 | |
| SCHEMBL20829978 | 0.89 | OPRK1 (0.62) | MEN1KMT2AHCRTR1IL1RNERAP2 | |
| SCHEMBL14941216 | 0.89 | ACE (0.68) | MEN1KMT2AACEMAPT | |
| SCHEMBL7422711 | 0.89 | ACE (0.68) | MEN1KMT2AACEMAPT | |
| SCHEMBL29603940 | 0.89 | ACE (0.68) | MEN1KMT2AACEMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9399661-B2 | Tetrapeptide copper catalysts capable of oxidizing hydrocarbons at room temperature | UNIVERSITY OF THE WEST INDIES (TT) | 2016-07-26 | — | — | US | disclosed |
| US-20160060292-A1 | Tetrapeptide Copper Catalysts Capable Of Oxidizing Hydrocarbons At Room Temperature | UNIVERSITY OF THE WEST INDIES (TT) | 2016-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160060292-A1 | Tetrapeptide Copper Catalysts Capable Of Oxidizing Hydrocarbons At Room Temperature | SOD1, SOD3, AOC1 | MEN1 2131/4885KMT2A 3995/4885HCRTR1 1706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.